SHKK(SH:600272) Xin Lang Cai Jing·2025-12-19 01:55Group 1 - The core viewpoint of the news is that Kaikai Industry's stock has experienced fluctuations, with a recent decline of 2.02% and a year-to-date drop of 4.06% [1][2] - As of December 19, the stock price is reported at 14.56 yuan per share, with a market capitalization of 3.824 billion yuan [1] - The company has seen a net inflow of main funds amounting to 2.2734 million yuan, with significant buying and selling activity [1] Group 2 - Kaikai Industry's stock has shown a slight increase of 0.41% over the last five trading days and a 4.67% increase over the last 20 days [2] - The company has made three appearances on the "Dragon and Tiger List" this year, with the most recent net buy of 49.9877 million yuan on December 4 [2] - The company was established on August 4, 1997, and went public on February 28, 2001, focusing on traditional Chinese medicine distribution and retail [2] Group 3 - The revenue composition of Kaikai Industry includes 74.48% from wholesale, 18.18% from retail, 4.42% from health services, 1.77% from leasing, and 1.14% from other sources [2] - As of September 30, 2025, the company reported a revenue of 825 million yuan, reflecting a year-on-year growth of 10.76%, while the net profit attributable to shareholders decreased by 62.81% to 12.8678 million yuan [2] - The company has distributed a total of 191 million yuan in dividends since its A-share listing, with 34.749 million yuan distributed in the last three years [3]